First, this is the first study to demonstrate that SEC23A mRNA expression is associated with the OS, DSS, and PFI in different cancers such as ACC, BLCA, CESC, KIRP, and UVM patients. This evidence concerns the gene SEC23A and bladder transitional cell carcinoma.